Literature DB >> 27888513

Decreased allopregnanolone levels in cerebrospinal fluid obtained during status epilepticus.

Stefano Meletti1,2, Chiara Lucchi1,2, Giulia Monti1, Giada Giovannini1, Roberta Bedin1,2, Tommaso Trenti3, Cecilia Rustichelli4, Giuseppe Biagini1,2.   

Abstract

Neuroactive steroids are increasingly considered as relevant modulators of neuronal activity. Especially allopregnanolone (AP) and pregnenolone sulfate (PS) have been shown to possess, respectively, anticonvulsant or proconvulsant properties. In view of the potential role of these steroids, we aimed at evaluating AP and PS levels in cerebrospinal fluid (CSF) and blood samples obtained from patients with status epilepticus (SE). To this purpose, we enrolled 41 patients affected by SE and 41 subjects investigated for nonepileptic neurologic disorders. Liquid chromatographic procedures coupled with electrospray tandem mass spectrometry and routine laboratory investigations were performed. Significantly lower AP levels were found in the CSF of patients affected by SE (-30%; p < 0.05, Mann-Whitney test). Notably, AP was not detectable in 28 of 41 patients affected by SE (p < 0.01 vs. controls, Fisher's exact test). In serum, AP levels did not differ in the two considered groups. Conversely, PS was present at similar levels in the investigated groups. Finally, differences in AP levels could not be explained by a variation in CSF albumin content. These findings indicate that AP is defective in the CSF of patients affected by SE. This phenomenon was not dependent on carriers for steroids, such as albumin. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  Allopregnanolone; Cerebrospinal fluid; LC-MS/MS; Pregnenolone sulfate; Status epilepticus

Mesh:

Substances:

Year:  2016        PMID: 27888513     DOI: 10.1111/epi.13625

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2017-11-15       Impact factor: 4.030

Review 2.  Neurosteroid regulation of GABAA receptors: A role in catamenial epilepsy.

Authors:  Suchitra Joshi; Jaideep Kapur
Journal:  Brain Res       Date:  2018-02-23       Impact factor: 3.252

Review 3.  Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Authors:  Doodipala Samba Reddy
Journal:  J Neuroendocrinol       Date:  2021-09-10       Impact factor: 3.870

Review 4.  Neurosteroids and Focal Epileptic Disorders.

Authors:  Maxime Lévesque; Giuseppe Biagini; Massimo Avoli
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 5.  Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy.

Authors:  Slobodan M Janković; Miralem Dješević; Snežana V Janković
Journal:  J Exp Pharmacol       Date:  2021-03-08

6.  Insertion of Calcium-Permeable AMPA Receptors during Epileptiform Activity In Vitro Modulates Excitability of Principal Neurons in the Rat Entorhinal Cortex.

Authors:  Dmitry V Amakhin; Elena B Soboleva; Anton V Chizhov; Aleksey V Zaitsev
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 7.  Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.

Authors:  Andreas Bjorefeldt; Sebastian Illes; Henrik Zetterberg; Eric Hanse
Journal:  Front Neural Circuits       Date:  2018-02-05       Impact factor: 3.492

Review 8.  Neurosteroids in Adult Hippocampus of Male and Female Rodents: Biosynthesis and Actions of Sex Steroids.

Authors:  Yasushi Hojo; Suguru Kawato
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

9.  Neurosteroids and Seizure Activity.

Authors:  Barbara Miziak; Magdalena Chrościńska-Krawczyk; Stanisław J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

10.  BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5α-Dihydroprogesterone and Pregnanolone Levels.

Authors:  Rossella Avallone; Chiara Lucchi; Giulia Puja; Alessandro Codeluppi; Monica Filaferro; Giovanni Vitale; Cecilia Rustichelli; Giuseppe Biagini
Journal:  Cells       Date:  2020-09-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.